Broken String Biosciences
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Biodata Innovation Centre Wellcome Genom...Phone Number
+44 1223786071Website
www.brokenstringbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Broken String Biosciences
Broken String Biosciences is a genomics company building a technology platform to drive the development of cell and gene therapies. The company is headquartered in Cambridge, United Kingdom.Explore more
Broken String Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Broken String Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Broken String Biosciences has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Broken String Biosciences
Check out if Broken String Biosciences is spiking on competitors!
Funding: Get notified immidiatlly once Broken String Biosciences has new funding data
Product Launch: Get notified when Broken String Biosciences launches new products
Earning: See what the market has to say on Broken String Biosciences recently announced quarterly report
Website visits: Recent activity has been detected on your website
Broken String Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Broken String Biosciences had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Broken String Biosciences
Find 3 more new buyers
Compare Similar Companies to Broken String Biosciences
Compare insights from companies similar to Broken String Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Broken String Biosciences
<$5M
11-50
Private
$15M
2020
SZ
Sabrina ZimmermanAssociate Director, Business Development
<$5M
11-50
Private
-
-
RA
Reza AzmakanExecutive Director, Director of Sterilization Department, Engineering Team, Calibration, Qualification
Company Profile Activity
Activity Insights
Broken String Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Broken String Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Broken String Biosciences.
Broken String Biosciences financials insights
Gather financial insights about Broken String Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$15M
Broken String Biosciences Tech Stack
A closer look at the technologies used by Broken String Biosciences
Most Recent Scoops
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Person-Based
Open Position
Open Position
Open Position
Broken String Biosciences News & Media
Broken String Biosciences Launches Catalyst Program to Shorten Gene Editing Therapy Development by Months
BOSTON & CAMBRIDGE, England--(BUSINESS WIRE)--Broken String Biosciences (“Broken String”), a leader in advancing gene editing safety, today opened its Catalyst Early Access Program (EAP) for developers of gene-edited therapies that allow for the detection of on- and off-target edits at high resolution, in days, in their own labs. The program allows select companies to use Broken String’s INDUCE-seq® platform as a first-of-its-kind offering for rapidly detecting on-target and off-target effectsBroken String Biosciences Appoints Laurence Reid and Brad Crutchfield to its Board of Directors
CAMBRIDGE, England--(BUSINESS WIRE)--Broken String Biosciences (“Broken String”), a genomics company enabling development of the next generation of more precise, safe, and effective cell and gene therapies, today announced the appointments of Laurence Reid, PhD, as Chairman, and Brad Crutchfield as Non-Executive Director (NED) of its Board of Directors. Bringing extensive commercial and leadership expertise to the Board, Laurence and Brad will play a pivotal role in providing strategic oversighBroken String Biosciences Appoints Steve Becker as Chief Commercial Officer
CAMBRIDGE, England--(BUSINESS WIRE)--Broken String Biosciences (“Broken String”), a genomics company driving development of the next generation of more precise, safe, and effective cell and gene therapies, today announced it has appointed Steve Becker as Chief Commercial Officer. An experienced global life sciences executive, Steve will guide the expansion of the Company’s commercial operations and implement a robust go-to-market strategy for its Next-Generation Sequencing (NGS)-based DNA breakBroken String Biosciences and the Francis Crick Institute Collaborate to Advance ALS Research
CAMBRIDGE, England & LONDON--(BUSINESS WIRE)--Broken String Biosciences (“Broken String”), a genomics company driving development of the next generation of more precise, safe, and effective cell and gene therapies, today announced it has entered a research collaboration with the Francis Crick Institute, a world-leading biomedical discovery institute dedicated to understanding the biology underlying health and disease. In partnership with leading researchers at the Crick, the project aims to dev
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Broken String Biosciences
Sign Up For FreeTo access detailed company insights
Broken String Biosciences is a genomics company building a technology platform to drive the development of cell and gene therapies. The company is headquartered in Cambridge, United Kingdom.... Read More
